Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility
yahoo.com
finance
2022-10-18 13:30:00

NOTTINGHAM, England, Oct. 18, 2022 /PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK. The Â£6 million project results in a state-of-the-art drug substance manufacturing capability that can deliver integrated support for customers from candidate selection through to early clinical development and beyond.

The expansion delivers multipurpose capacity of up to 15 GMP reactor streams with reactor volumes ranging from 5 liters up to 150 liters and tactical deployment of batch or continuous flow chemistry technologies to optimize drug substance manufacturing processes.
